In Vitro & In Vivo Diagnostic Substances
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Saba Capital Management, L.P. | 199.8K | -- | 6.75% | -- | 2026-06-30 |
| Clear Street Group Inc. | 82.3K | -- | 2.78% | -- | 2026-06-30 |
| Context Capital Management, LLC | 81.5K | -- | 2.75% | -- | 2026-06-30 |
| D. E. Shaw & Co., Inc. | 74.8K | -- | 2.53% | -- | 2026-06-30 |
| Boothbay Fund Management, LLC | 60.5K | -- | 2.05% | -- | 2026-06-30 |
